Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filedfiledCritical
Priority to ECSP982519priorityCriticalpatent/ECSP982519A/en
Publication of ECSP982519ApublicationCriticalpatent/ECSP982519A/en
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Abstract
La invención se refiere a análogos de péptido LH-RH con una excelente afinidad para los receptores de LH-RH de la fórmula: A1-A2-A3-A4-A5-A6-HAA-A7-PROZ (I) Asi mismo, la invención se refiere a los usos de los citados análogos de péptido y a las composiciones farmacéuticas que los contienen.The invention relates to LH-RH peptide analogues with excellent affinity for LH-RH receptors of the formula: A1-A2-A3-A4-A5-A6-HAA-A7-PROZ (I) Likewise, the The invention relates to the uses of the said peptide analogues and to the pharmaceutical compositions containing them.
ECSP9825191998-06-021998-06-02
ANALOGS OF THE LH-RH PEPTIDE, ITS USES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
ECSP982519A
(en)
COMPOUNDS THAT LINK TO AND ACTIVATE A THROMBOPOYETIN RECEPTOR, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND THEIR USE FOR THE PREPARATION OF MEDICINES